Bioactivity

The ability to estimate the probability of a drug to receive approval in clinical trials provides natural advantages to optimizing pharmaceutical research workflows. Success rates of a clinical trials have deep implications to costs, duration of development, and under pressure due to stringent regulatory approval processes. We propose a machine learning approach that can predict the outcome of trial with reliable accuracies, using biological activities, physico-chemical properties of the compounds, target related features and NLP-based compound representation.